Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/3714409

Documents

Beta release

Statistics of Anti-GM-CSF otilimab versus tofacitinib or placebo in patients with active rheumatoid arthritis and an inadequate response to conventional or biologic DMARDs
Statistics for this year
PeriodVisitsDownloads
20243534
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0933
2024-1088
2024-1100